Liposomal Vitamin C

VitaSomal C® is a clinically studied and TruLiposome® Validated liposomal Vitamin C that offers better bioavailability for supercharged benefits!

The Vitamin C That Gives You More!

  • 27% More Bioavailable than Non-Liposomal Vitamin C
  • VitaSomal C® Stays in the White Blood Cells for Over 24 Hours
  • Backed by a Peer-Reviewed Clinical Study Conducted in the USA
  • VitaSomal C® helps support a healthy immune system and overall health
  • The Only Liposomal Vitamin C Verified by TruLiposome® Validation
  • Same Immune Health Benefits with a Smaller Daily Dose
  • Protected by DualHydrogel® Technology to further increase stability in the body
  • VitaSomal C® has been shown to be dramatically more stable in the body compared to non-liposomal Vitamin C

TruLiposome® Validation

LipoVantage® liposomes are the most sophisticated nutrient delivery system available today and they are the only liposomes backed by Specnova’s TruLiposome® Validation. Every batch of LipoVantage® liposomes is tested in a 6-step validation process ensuring that they meet ALL criteria required to be a true liposome.

TruLiposome®-Validation

VitaSomal C® is Supported by a Published Clinical Study

Purpura M, Jäger R, Godavarthi A, Bhaskarachar D, Tinsley GM. Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, randomized trial. Eur J Nutr. 2024 Sep 6. doi: 10.1007/s00394- 024-03487-8. https://link.springer.com/article/10.1007/s00394-024-03487-8

Abstract

Purpose: L-Ascorbic acid (vitamin C) is an essential water-soluble vitamin that plays an important role in various physiological functions, including immune health. The stability of vitamin C in the gastrointestinal tract and its bioavailability is limited. This study aimed to investigate if a liposomal form of vitamin C can increase absorption compared to standard vitamin C.

Methods: In a randomized, double-blind, placebo-controlled, crossover fashion, 19 males and 8 females (n = 27; 36.0 ± 5.1 years, 165.0 ± 6.9 cm, 70.6 ± 7.1 kg) ingested a single-dose of placebo (PLA), 500 mg vitamin C (VIT C), and 500 mg liposomal vitamin C (LV-VIT C, LipoVantage®, Specnova, LLC, Tyson Corner, VA, USA). Venous blood samples were collected 0, 0.5-, 1-, 1.5-, 2-, 3-, 4-, 6-, 8-, 12-, and 24-hours after ingestion and were analyzed for plasma and leukocyte vitamin C concentration.

Results: VIT C and LV-VIT C demonstrated significantly greater Cmax and AUC0 − 24 in plasma and in leukocytes compared to placebo (p < 0.001). Additionally, LV-VIT C had significantly higher Cmax (plasma + 27%, leukocytes + 20%, p < 0.001) and AUC0 − 24 (plasma + 21%, leukocytes + 8%, p < 0.001) values as compared to VIT C.

Conclusion: The Liposomal formulation of vitamin C increases absorption into plasma and leukocytes.1